UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Honesty, trust and integrity

British dental journal, 2023-08, Vol.235 (3), p.162-162

Ladwa, R

2023

Volltextzugriff (PDF)

A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)

Cancer Immunology, Immunotherapy, 2021-03, Vol.70 (3), p.743-753

2021

Volltextzugriff (PDF)

Dental radiography: Cherry picking evidence

British dental journal, 2017-07, Vol.223 (1), p.4-4

2017

Volltextzugriff (PDF)

Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein

PloS one, 2016-02, Vol.11 (2), p.e0148266

2016

Volltextzugriff (PDF)

Review of Oral Surgery Services and Training: a case of prescription without a diagnosis

British journal of oral & maxillofacial surgery, 2013-01, Vol.51 (1), p.2-5

2013

Volltextzugriff (PDF)

Perio pictures (CD-ROM)

British dental journal, 2007-08, Vol.203 (4), p.218-218

Ladwa, R

2007

Volltextzugriff (PDF)

P9 Determining the appropriate D-dimer cut-off to exclude pulmonary emboli in an ambulatory care setting using different thresholds based on pre-test probability

Thorax, 2011-12, Vol.66 (Suppl 4), p.A70-A70

2011

Volltextzugriff (PDF)

P226 Managing suspected pulmonary embolism in an ambulatory setting: the Leicester experience

Thorax, 2011-12, Vol.66 (Suppl 4), p.A160-A160

2011

Volltextzugriff (PDF)

EP11.03-20 Real World Experience of First Line Pembrolizumab for Non-Small Cell Lung Cancer (NSCLC) at a Tertiary Centre

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S628-S629

2023

Volltextzugriff (PDF)

EP08.02-02 Real World Chemoradiotherapy Outcomes for Frail Older Adults with Unresectable Stage III Non Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S568

2023

Volltextzugriff (PDF)

1144P High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study

Annals of oncology, 2023-10, Vol.34, p.S685-S685

2023

Volltextzugriff (PDF)

Complete responders to anti-PD1 antibodies. What happens when we stop?

Annals of oncology, 2016-10, Vol.27, p.vi382-vi382

2016

Volltextzugriff (PDF)

EP04.01-013 Frailty Index Predicts Treatment Outcomes in Older Adults with Lung Cancer

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S251

2022

Volltextzugriff (PDF)

A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients with Resectable Cutaneous Squamous Cell Carcinoma (cSCC)

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e86-e86

2024

Volltextzugriff (PDF)

P24.10 Identification of ctDNA using MassARRAY Technology in a Cross-Sectional Study of NSCLC Patients

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1034-S1035

2021

Volltextzugriff (PDF)

CT texture analysis as a predictor of effectiveness of second line nivolumab in metastatic non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2019-01, Vol.127, p.S16-S17

2019

Volltextzugriff (PDF)

EP08.04-002 Australian Vinorelbine Use in Advanced Lung cancer (The AVAL Study)

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S495

2022

Volltextzugriff (PDF)

P3.01-74 Clinical and Radiological Predictors of Efficacy to Nivolumab in NSCLC: A Multi-Institutional, Retrospective Cohort Study

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S895-S895

2018

Volltextzugriff (PDF)

654MO High dimensional immuno-phenotyping of immunotherapy response in head and neck cancer

Annals of oncology, 2022-09, Vol.33, p.S841

2022

Volltextzugriff (PDF)

TS01.06 High-Plex Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2021-01, Vol.16 (1), p.S50-S50

2021

Volltextzugriff (PDF)

The impact of tumour absorbed dosimetry with survival outcomes after peptide receptor radionuclide therapy in metastatic neuroendocrine tumours

Annals of oncology, 2019-10, Vol.30, p.v570

2019

Volltextzugriff (PDF)

1394P - The impact of tumour absorbed dosimetry with survival outcomes after peptide receptor radionuclide therapy in metastatic neuroendocrine tumours

Annals of oncology, 2019-10, Vol.30, p.v570-v570

2019

Volltextzugriff (PDF)

Mealy-mouthed rhetoric

British dental journal, 2007-04, Vol.202 (7), p.369-369

2007

Volltextzugriff (PDF)

P1.01-119 Modified Lung Immune Prognostic Index (mLIPI) as a Predictive Tool of Nivolumab Outcomes in Advanced NSCLC Patients

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S408-S409

2019

Volltextzugriff (PDF)

818P Phase II confirmatory study of cemiplimab (350mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6

Annals of oncology, 2022-09, Vol.33, p.S921

2022

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(59)
Tagungsberichte
(2)

Sprache

Englisch
(61)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(9)
Journal Of Thoracic Oncology
(9)
British Dental Journal
(5)
Chemmedchem
(5)
Ejc Skin Cancer
(4)
Thorax
(3)
Journal Of Clinical Oncology
(2)
Plos One
(2)
Applied Microbiology And Biotechnology
(1)
Bjs Open
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Honesty, trust and integrity

A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)

Dental radiography: Cherry picking evidence

Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein

Review of Oral Surgery Services and Training: a case of prescription without a diagnosis

Perio pictures (CD-ROM)

P9 Determining the appropriate D-dimer cut-off to exclude pulmonary emboli in an ambulatory care setting using different thresholds based on pre-test probability

P226 Managing suspected pulmonary embolism in an ambulatory setting: the Leicester experience

EP11.03-20 Real World Experience of First Line Pembrolizumab for Non-Small Cell Lung Cancer (NSCLC) at a Tertiary Centre

EP08.02-02 Real World Chemoradiotherapy Outcomes for Frail Older Adults with Unresectable Stage III Non Small Cell Lung Cancer (NSCLC)

1144P High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study

Complete responders to anti-PD1 antibodies. What happens when we stop?

EP04.01-013 Frailty Index Predicts Treatment Outcomes in Older Adults with Lung Cancer

A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients with Resectable Cutaneous Squamous Cell Carcinoma (cSCC)

P24.10 Identification of ctDNA using MassARRAY Technology in a Cross-Sectional Study of NSCLC Patients

CT texture analysis as a predictor of effectiveness of second line nivolumab in metastatic non-small cell lung cancer

EP08.04-002 Australian Vinorelbine Use in Advanced Lung cancer (The AVAL Study)

P3.01-74 Clinical and Radiological Predictors of Efficacy to Nivolumab in NSCLC: A Multi-Institutional, Retrospective Cohort Study

654MO High dimensional immuno-phenotyping of immunotherapy response in head and neck cancer

TS01.06 High-Plex Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC)

The impact of tumour absorbed dosimetry with survival outcomes after peptide receptor radionuclide therapy in metastatic neuroendocrine tumours

1394P - The impact of tumour absorbed dosimetry with survival outcomes after peptide receptor radionuclide therapy in metastatic neuroendocrine tumours

Mealy-mouthed rhetoric

P1.01-119 Modified Lung Immune Prognostic Index (mLIPI) as a Predictive Tool of Nivolumab Outcomes in Advanced NSCLC Patients

818P Phase II confirmatory study of cemiplimab (350mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6

Suchergebnisse filtern